Position history for BlackRock, Inc.'s holdings in CATALYST PHARMACEUTICALS INC
BlackRock, Inc. holds 18.8M shares of CPRX (CATALYST PHARMACEUTICALS INC), worth $464.9M as of 2026-Q1. The position was increased (+0.8% shares). CPRX represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$464.9M
Current Shares
18.8M
Total Value Change
+$59.5M
Total Shares Change
-650,599
Other major holders of CPRX: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 18.8M |
+0.8% |
| $464.9M |
| 0.0% |
| $23.92 |
31 |
| 2025-Q4 | Increased | 18.6M | +2.3% | $434.7M | 0.0% | $23.29 | 32 |
| 2025-Q3 | Decreased | 18.2M | -3.6% | $358.9M | 0.0% | $19.55 | 0 |
| 2025-Q2 | Increased | 18.9M | +0.5% | $410.1M | 0.0% | $21.78 | 31 |
| 2025-Q1 | Decreased | 18.8M | -3.2% | $456M | 0.0% | $24.69 | 0 |
| 2024-Q4 | New | 19.4M | - | $405.4M | 0.0% | $21.07 | 43 |